ArticleBritish journal of clinical pharmacology2021

Intestinal SGLT1 as a therapeutic target in COVID-19-related diabetes: A "two-edged sword" hypothesis.

Theocharis Koufakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.